INSEAD: One School, Two Campuses – Going to Asia

In the late 1990s, INSEAD stood at a crossroads: to one side was the status quo, a continuation of its expansion on the Fontainebleau campus; to the other was a bold step, a further commitment to the Asian market by opening a second campus in the region. Professors Lasserre and De Meyer, and Sam Garg provide an analysis and chronology of the decision-making process. … [ Read more ]

CP Group: From Seeds to ‘Kitchen of the World’

Thailand’s CP Group became Asia’s largest agro-industrial company through the development and geographic expansion of its vertically integrated system. In this new Case Study, Professor Peter Williamson and Keeley Wilson explain how CP build the capabilities required for success and used alliances and joint ventures to expand beyond its core business and into processed foods.

Marketing Strategies in the Competition Between Branded and Generic Antibiotics (A): Clamoxyl in 1996, (B): Augmentin in 2002

The high cost of pharmaceuticals is a serious concern for government officials trying to reduce health care expenditures. In this new Case Study, Professor Chandon and Research Associate Sarah Spargo, look at the battle between branded and generic prescription drugs, and explain how SmithKline Beecham reacted to a direct attack on one of their ‘jewel’ drugs.

Regulatory Challenges Facing U.S. Equity Markets

The issues that confront the SEC and the U.S. equity markets are highly complex. While the SEC has not set a timetable to resolve these issues, it is clear that speedy resolution is imperative for the survival of many markets.